Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Immediate Simultaneous Bilateral Cataract Surgery (ISBCS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Panhandle Eye Group, LLP
Information provided by (Responsible Party):
Sloan W. Rush, MD, Panhandle Eye Group, LLP Identifier:
First received: April 18, 2013
Last updated: October 2, 2016
Last verified: October 2016
To evaluate the safety and efficacy of treating visually significant bilateral cataract with the newer technique of Immediate Simultaneous Bilateral Cataract Surgery (ISBCS) versus the conventional technique of Delayed Sequential Bilateral Cataract Surgery (DSBCS) in a select patient population.

Condition Intervention
Bilateral Cataract
Procedure: ISBCS
Procedure: DSBCS

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Immediate Simultaneous Bilateral Cataract Surgery: A Prospective, Case-controlled Clinical Trial in the United States

Resource links provided by NLM:

Further study details as provided by Panhandle Eye Group, LLP:

Primary Outcome Measures:
  • Visual acuity [ Time Frame: 3 weeks ]
    Best uncorrected and best spectacle corrected post-operative visual acuity

Secondary Outcome Measures:
  • Recovery time and number of post-operative visits [ Time Frame: 6 months ]

Estimated Enrollment: 2000
Study Start Date: April 2013
Estimated Primary Completion Date: April 2018 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: ISBCS
Immediate Simultaneous Bilateral Cataract Surgery
Procedure: ISBCS
same-day cataract surgery
Active Comparator: DSBCS
Delayed Sequential Bilateral Cataract Surgery
Procedure: DSBCS
bilateral surgery delayed by 1-3 weeks amongst eyes


Ages Eligible for Study:   30 Years to 100 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age 30-100
  • Candidate for topical anesthesia
  • Signed the informed consents

Exclusion Criteria:

  • Allergies to medications used in study
  • Cannot have topical anesthesia
  • Unwilling to participate in research trial
  • Have any other significant ocular comorbidities
  • Have known systemic immuno-compromised state
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01841957

Contact: Sloan Rush, MD 806-353-0125
Contact: Sunday Fowler 806-353-0125

United States, Texas
Panhandle Eye Group Recruiting
Amarillo, Texas, United States, 79106
Contact: Sunday Fowler    806-353-0125      
Principal Investigator: Sloan Rush         
Sponsors and Collaborators
Sloan W. Rush, MD
  More Information

Responsible Party: Sloan W. Rush, MD, MD, Panhandle Eye Group, LLP Identifier: NCT01841957     History of Changes
Other Study ID Numbers: 2
Study First Received: April 18, 2013
Last Updated: October 2, 2016

Keywords provided by Panhandle Eye Group, LLP:
Bilateral Cataract
Simultaneous Cataract Surgery

Additional relevant MeSH terms:
Lens Diseases
Eye Diseases processed this record on May 22, 2017